Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Class A Common Shares
Symbol
CRDL on Nasdaq
Shares outstanding
117,125,812
Price per share
$0.96
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
7,942,974
Total reported value
$7,583,239
% of total 13F portfolios
0%
Share change
+2,509,021
Value change
+$2,374,762
Number of holders
31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MMCAP International Inc. SPC 15% $21,116,613 17,451,746 MMCAP International Inc. SPC 23 Jan 2026
Tejara Capital Ltd 5.2% $5,323,528 5,130,122 Tejara Capital Ltd 17 Oct 2025

As of 31 Dec 2025, 31 institutional investors reported holding 7,942,974 shares of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL). This represents 6.8% of the company’s total 117,125,812 outstanding shares.

Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,942,974 $7,583,239 +$2,374,762 $0.95 31
2025 Q3 7,282,619 $7,797,682 +$687,878 $1.07 47
2025 Q2 6,465,422 $8,796,830 -$1,669,184 $1.36 38
2025 Q1 7,719,601 $7,435,013 +$182,305 $0.97 38
2024 Q4 7,493,301 $9,599,808 +$3,011,551 $1.28 43
2024 Q3 4,972,709 $9,852,940 -$780,395 $1.98 41
2024 Q2 5,391,195 $10,832,854 -$2,207,214 $2.02 41
2024 Q1 6,466,600 $11,532,275 +$17,221 $1.81 32
2023 Q4 6,828,316 $5,921,144 +$428,207 $0.84 29
2023 Q3 6,315,038 $5,705,102 -$336,357 $0.90 31
2023 Q2 6,680,430 $5,957,333 -$451,394 $0.89 30
2023 Q1 7,243,437 $3,537,761 +$172,240 $0.49 31
2022 Q4 5,656,495 $2,897,996 +$187,861 $0.51 28
2022 Q3 4,751,290 $4,889,869 -$537,769 $1.03 22
2022 Q2 5,288,416 $6,964,240 -$155,145 $1.32 24
2022 Q1 5,387,006 $8,272,481 -$917,566 $1.54 26
2021 Q4 5,796,080 $10,710,997 +$7,739,960 $1.85 27
2021 Q3 1,605,991 $6,624,465 +$6,624,465 $4.13 19
2021 Q1 0 $0 -$970,000 $0.96 0
2020 Q4 348,769 $970,000 +$171,498 $2.78 1
2020 Q3 287,106 $876,000 +$133,036 $3.05 1
2020 Q2 243,504 $577,000 +$78,276 $2.37 1
2020 Q1 210,470 $600,000 +$50,715 $2.85 1
2019 Q4 192,680 $681,000 $3.53 1